Jeuveau is a French Botox alternative recently approved by the FDA that targets frown lines between the eyebrows. Its referring domains have increased substantially after being at zero at the beginning of the summer.
Next steps: Botox has been the gold standard for reducing wrinkles, and Jeuveau has joined treatments like Dysport and Xeomin in trying to replicate its success. Jeuveau is typically the least expensive and has also used a millennial-centric marketing scheme. Botox-related procedures are up 800% since 2000, in part because millennials seek preventative injections.